GenScript Biotech Holdings faces renewed US scrutiny over national security concerns

Source:SCMP

02 — Who / Subject

GenScript Biotech Holdings

03 — Where / Locus

Hong Kong / USA

04 — When / Temporality

June 3, 2026

Verified: June 3, 2026

05 — Why / Core Summary

"GenScript Biotech shares surged 29% after the company rejected allegations of national security risks. US lawmakers requested updated information from the FBI and intelligence agencies regarding the company's ties to Beijing."

Conflict Analysis

The company is navigating geopolitical tensions between the US and China regarding biotechnology and data security.

Post

COMPAMIR

COMPAMIR

GenScript Biotech Holdings faces renewed US scrutiny over national security concerns